Zephyrnet Logo

Bausch, Salix’s Trimmed IBS Drug IP Suit Moves to W.Va.

Date:

A New Jersey federal judge on Tuesday dismissed several Mylan entities from a patent suit relating to their purported plans to market generic versions of gastrointestinal drug Trulance, while also tossing a number of patent claims and sending the remainder to West Virginia federal court.

spot_img

Latest Intelligence

spot_img